Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05
Journal of Gastroenterology · 22.05.2026
DOI: 10.1007/s00535-026-02441-1 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology, online erschienen am 22.05.2026. Verfasst von Yi Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China.
- Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China. yuechaochi18@swmu.edu.cn.
Zitieren
APA
Luo, Y., & Yue, C. C. (2026). Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02441-1
Vancouver
Luo Y, Yue CC. Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02441-1
BibTeX
@article{Luo2026,
author = {Luo, Yi and Yue, Chao-Chi},
title = {Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02441-1}
}
EUVIMED